sglt2 vs glp 1 Disparities in Inhibitor or Glucagon-Like Peptide Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States GLP1 Receptor Agonists vs SGLT2-I
Description
This analysis confirmed a significant association between GLP-1 RAs and these NAEs (ROR 1.44, 95% CI 1.411.46), with variation observed across different GLP-1 RAs (Fig
The truth is no
So far, data from diabetes use is reassuring, but there is not yet decades of information for weight loss use
Because these medications are ongoing treatments, understanding long-term costs is an important part of planning
J Dermatol Dermatol Surg 23(2):9798
